Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

The primary reasons for treatment were presumed pulmonary aspergillosis (n = 83, 76.8%), other invasive mould infections (n = 13, 12.0%) and candidiasis (n = 9, 8.3%). There was a high degree of ...

AIDS is defined by a CD4+ cell count below 200 cells per cubic millimeter of blood or the presence of AIDS-defining conditions, such as pulmonary candidiasis, primary lymphoma of the brain ...

AIDS is defined by a CD4+ cell count below 200 cells per cubic millimeter of blood or the presence of AIDS-defining conditions, such as pulmonary candidiasis, primary lymphoma of the brain, or Kaposi ...

Staffing constraints are the single greatest challenge to maintaining clinical excellence in 2025, followed by insufficient ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Transtracheal aspiration failed to yield the pathogen causing pulmonary infection in 1 ... resistant micro-organisms (including Candida albicans); lesser opportunity for development of ...

Together with a team of international clinical researchers, Professor Dr. Oliver A. Cornely and Dr. Rosanne Sprute from ...

In just a decade, the drug-resistant fungal pathogen Candida auris (C. auris) has emerged as one of the most formidable threats to health care settings worldwide. Nowhere in the United States is this ...